Paradigm Asset Management CO LLC Abb Vie Inc. Transaction History

Paradigm Asset Management CO LLC

$249 Million
Q1 2025

A detailed history of Paradigm Asset Management CO LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Paradigm Asset Management CO LLC holds 14,400 shares of ABBV stock, worth $2.67 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares

14,400

Previous 14,400 -0.0%

Holding current value

$2.67 Million

Previous $2.56 Million 17.94%

% of portfolio

1.21%

Previous 1.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	BUY	$164.99 - $203.87 $362,978 - $448,514	2,200 Added 18.03%	14,400 $2.56 Million
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $1.51 Million - $1.76 Million	-9,750 Reduced 44.42%	12,200 $2.09 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $87,901 - $100,155	-550 Reduced 2.44%	21,950 $4 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $82,560 - $92,982	-600 Reduced 2.6%	22,500 $3.49 Million
Q3 2023 Oct 31, 2023	SELL	$133.59 - $154.65 $173,667 - $201,045	-1,300 Reduced 5.33%	23,100 $3.44 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $1.05 Million - $1.3 Million	7,900 Added 47.88%	24,400 $3.29 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $1.7 Million - $2.04 Million	12,300 Added 292.86%	16,500 $2.67 Million
Q3 2022 Nov 09, 2022	SELL	$134.21 - $153.93 $93,947 - $107,751	-700 Reduced 14.29%	4,200 $564 Million
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $674,338 - $857,304	4,900 New	4,900 $750,000
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $672,091 - $907,394	-8,350 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $506,253 - $677,442	6,900 Added 475.86%	8,350 $819,000
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $14,426 - $18,050	200 Added 16.0%	1,450 $128,000
Q2 2019 Aug 08, 2019	SELL	$65.7 - $83.98 $522,315 - $667,641	-7,950 Reduced 86.41%	1,250 $0
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $61,712 - $72,632	-800 Reduced 8.0%	9,200 $0
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $70,065 - $86,409	-900 Reduced 8.26%	10,000 $921,000
Q3 2018 Nov 19, 2018	SELL	$88.91 - $98.84 $1.05 Million - $1.17 Million	-11,800 Reduced 51.98%	10,900 $0
Q1 2018 May 07, 2018	SELL	$92.01 - $123.21 $110,412 - $147,852	-1,200 Reduced 5.02%	22,700 $0
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $2.14 Million - $2.35 Million	23,900	23,900 $0

Others Institutions Holding ABBV

# of Institutions

4,260

Shares Held

1.27B

Call Options Held

18.2M

Put Options Held

15.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $328B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Asset Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Asset Management CO LLC with notifications on news.

Account

Paradigm Asset Management CO LLC Abb Vie Inc. Transaction History